Kulkarni Samarth

Kulkarni Samarth is listed in filings as Director at Repare Therapeutics Inc.. This profile follows SEC Form 4 activity through Mar 24, 2026, including sale activity. Recent filings connect the profile to Repare Therapeutics Inc. (RPTX), Oruka Therapeutics, Inc. (ORKA), CRISPR Therapeutics AG-Common Shares (CRSP), and Centessa Pharmaceuticals plc (CNTA). The current snapshot covers public activity from Jun 20, 2024 to Mar 24, 2026. Reported amounts are shown as $103.4K to $198.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.